SCHEMBL31293526

SCHEMBL31293526

CC(C)(C)OC(=O)N1CC2(CC(CC(=O)Nc3cccc(C(F)(F)F)c3)C2)C1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
MAPT P10636 2/20 0.48
GAA P10253 1/20 0.48
XBP1 P17861 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 2/20 0.46
AURKB Q96GD4 1/20 0.45
TSHR P16473 1/20 0.45
ABHD6 Q9BV23 2/20 0.44
POLB P06746 1/20 0.44
GRIN2B Q13224 2/20 0.44
MGLL Q99685 1/20 0.44
ALDH1A1 P00352 2/20 0.43
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31293787 0.84 EPHX2 (0.57) MEN1KMT2AMAPTXBP1ALDH1A1
SCHEMBL20983843 0.84 ABHD6 (0.47) SMN1; SMN2KMT2AMAPTRXFP1ABHD6
SCHEMBL31293771 0.82 DCUN1D1 (0.47) RXFP1POLB
SCHEMBL31294047 0.78 SMN1; SMN2 (0.55) SMN1; SMN2MEN1KMT2AMAPTGAA
SCHEMBL31294042 0.77 GRIN2B (0.51) SMN1; SMN2MEN1KMT2AMAPTGAA
SCHEMBL20983865 0.76 ABHD6 (0.72) MEN1KMT2AABHD6MGLLEPHX2
SCHEMBL6863428 0.76 TACR1 (0.48) MAPTALDH1A1
SCHEMBL32660716 0.76 MAPT (0.69) SMN1; SMN2MEN1KMT2AMAPTGAA
SCHEMBL18658290 0.75 UBE2M (0.67) SMN1; SMN2MEN1KMT2AMAPTRXFP1
SCHEMBL29491079 0.75 UBE2M (0.67) SMN1; SMN2MEN1KMT2AMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724439-A1 HETEROARYL DERIVATIVES AS DDRS INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2026-04-15 EP disclosed
WO-2024251855-A1 HETEROARYL DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-12-12 WO disclosed